IMAN LEE: Open Payments
NPI 1821875626 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 90 payments from 17 companies in 2025. Trend: 2023 $14 · 2024 $2,020 · 2025 $1,910
Food & beverage: $1,910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $322 |
| PFIZER INC. | 14 | $296 |
| ViiV Healthcare Company | 9 | $240 |
| Gilead Sciences, Inc. | 12 | $216 |
| Novo Nordisk Inc | 11 | $207 |
| Lilly USA, LLC | 5 | $105 |
| Amgen Inc. | 4 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Exact Sciences Corporation | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
Products named: APRETUDE, Ozempic, UBRELVY, NURTEC ODT, ELIQUIS, PREVNAR 20, MOUNJARO, QULIPTA.
Industry payments across VA — which companies pay providers there.
